Intestinal permeation enhancers (PEs) are one of the most widely tested strategies to improve oral delivery of therapeutic peptides. This article assesses the intestinal permeation enhancement action of over 250 PEs that have been tested in intestinal delivery models. In depth analysis of pre-clinical data is presented for PEs as components of proprietary delivery systems that have progressed to clinical trials. Given the importance of co-presentation of sufficiently high concentrations of PE and peptide at the small intestinal epithelium, there is an emphasis on studies where PEs have been formulated with poorly permeable molecules in solid dosage forms and lipoidal dispersions.
Maher, S., Mrsny, R., & Brayden, D. J. (2016). Intestinal permeation enhancers for oral peptide delivery. Advanced Drug Delivery Reviews, 106(Part B), 277-319. https://doi.org/10.1016/j.addr.2016.06.005